ClinicalTrials.gg
Active, not recruitingNCT07932015CP-POSUpdated Nov 17, 2026

Leg Muscle Activity and Heart Rate in Different Body Positions in Children With Cerebral Palsy

An observational study in Cerebral Palsy, sponsored by Klaipėda University. Active, not recruiting at 1 site in Lithuania. Open to participants aged 3 Years to 16 Years. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Klaipėda University · Observational

Updated Nov 12, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
6
Ages
3 Years to 16 Years
Sex
All
01

Study summary

This observational study examines leg muscle activity during supported standing and heart rate in different body positions in children aged 3-16 years with cerebral palsy who receive palliative care and have severe limitations in movement (Gross Motor Function Classification System levels IV-V).

Heart rate is recorded while lying and sitting for all participants. Children who can undergo supported standing as part of their usual care also have heart rate and leg muscle activity recorded while standing. Small sensors placed on the skin measure muscle electrical activity. Standing duration and any signs of discomfort are documented.

The researchers do not assign standing as a treatment. The study records responses during routine care.

Read the detailed description

This single-center observational study is conducted in a pediatric palliative care department in Klaipeda, Lithuania. Measurements are scheduled at weekly intervals, in the morning before breakfast, with one body position assessed at each visit: lying at the first visit, sitting at the second visit, and supported standing at the third visit where clinically appropriate.

Heart rate is recorded using a Polar H10 sensor for 20 minutes in lying and 20 minutes in sitting. During supported standing, heart rate and surface electromyography are recorded for up to 20 minutes, depending on tolerance. Participants with contraindications to standing undergo lying and sitting measurements only.

Surface electromyography is recorded bilaterally from the rectus femoris, biceps femoris, gluteus maximus, and lateral head of the gastrocnemius using the Biometrics DataLINK system. Root mean square amplitude is calculated in microvolts over the entire recorded standing period, separately for each muscle and side.

Mean heart rate is calculated over the entire recording for each body position. Standing tolerance is documented through actual standing duration, time to the first observed sign of discomfort, and free-text notes describing the child's condition and reasons for early termination. If no discomfort occurs, this is documented as no discomfort observed during the session. No standardized tolerance scale is used.

Lying and sitting heart rate measurements are compared within participants. Comparisons involving standing are limited to participants with standing recordings. Muscle activity is assessed during standing only.

02

Conditions studied

  • Cerebral Palsy

Browse trials for

Keywords

  • Supported standing
  • Body position
  • Surface electromyography
  • Muscle activity
  • Heart rate
  • Pediatric palliative care
  • GMFCS IV-V
03

In context

Cerebral Palsy

1,941 studies on the registry are indexed under Cerebral Palsy; 459 are open to participants now.

This study's planned enrollment of 6 is below the median of 63 across 474 observational studies indexed under Cerebral Palsy.

Browse Cerebral Palsy studies →

Lead sponsor

Klaipėda University is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Children aged 3-16 years with cerebral palsy, GMFCS levels IV-V, receiving care in the palliative care department of Biudžetinė įstaiga Klaipėdos sutrikusio vystymosi kūdikių namai, Klaipeda, Lithuania. Participants may include children admitted for respite care or supportive treatment. Both children who can undergo supported standing and those assessed only in lying and sitting positions are eligible.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 3-16 years.
  • Diagnosis of cerebral palsy.
  • Gross Motor Function Classification System (GMFCS) level IV or V.
  • Receiving care in the participating pediatric palliative care department.
  • Written provided by a parent or legally authorized representative.

Exclusion criteria

Exclusion Criteria:

  • Acute infection.
  • Uncontrolled epilepsy.
  • Changes in body position trigger myoclonus and/or epileptic seizures.

Eligibility for standing measurements:

  • Supported standing is part of routine care and is not .
  • Participants with contraindications to supported standing remain eligible for heart rate measurements in lying and sitting positions only.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
6 participants (estimated)
Patient registry
No

Groups and cohorts

  • Children With Cerebral Palsy Receiving Palliative Care

    Children aged 3-16 years with cerebral palsy, GMFCS levels IV-V, receiving palliative care. All participants undergo heart rate recording while lying and sitting. Participants who can undergo supported standing as part of routine care additionally undergo heart rate and surface electromyography recording during standing. Participants with contraindications to standing undergo lying and sitting measurements only.

    Other: Routine Care Positioning

Interventions

  • OtherRoutine Care Positioning

    Lying, sitting, and, where clinically appropriate, supported standing provided as part of routine care. Positioning is not assigned by the investigators. Heart rate is recorded in each assessed position, and surface electromyography is recorded during supported standing only.

06

What researchers measure

Primary outcomes

  1. Lower-Limb Surface Electromyography RMS Amplitude During Supported Standing

    Surface electromyography root mean square (RMS) amplitude, expressed in microvolts (µV), calculated over the entire recorded supported-standing period. Measurements are obtained bilaterally from the rectus femoris, biceps femoris, gluteus maximus, and lateral head of the gastrocnemius using the Biometrics DataLINK system. Values are reported separately for each muscle and side, without normalization. This outcome is assessed only in participants undergoing supported standing as part of routine care.

    Time frame: During one supported-standing session lasting up to 20 minutes, approximately two weeks after the first measurement visit.

Secondary outcomes

  1. Mean Heart Rate in Different Body Positions

    Mean heart rate, expressed in beats per minute, calculated over the entire recording in each position. All participants are assessed while lying and sitting. Participants able to undergo supported standing are additionally assessed while standing. Recordings are obtained using a Polar H10 sensor on separate days at weekly intervals, in the morning before breakfast.

    Time frame: During 20-minute lying and sitting recordings and up to 20 minutes of supported standing, across approximately two weeks.

  2. Duration of Supported Standing

    Actual supported-standing duration, expressed in minutes, up to a planned maximum of 20 minutes. Assessed only in participants undergoing supported standing. Reasons for early termination are documented in free-text notes.

    Time frame: During one supported-standing session lasting up to 20 minutes, approximately two weeks after the first measurement visit.

  3. Time to First Observed Sign of Discomfort During Supported Standing

    Time in minutes from the start of supported standing to the first observed sign of discomfort, such as crying, restlessness, or pain-related behavior, documented in observational notes. If no signs occur, this is recorded as no discomfort observed during the actual session; the session end is not treated as a discomfort event.

    Time frame: During one supported-standing session lasting up to 20 minutes, approximately two weeks after the first measurement visit.

07

Study locations

1 site
08

References and documents

Publications

  • Paleg GS, Williams SA, Livingstone RW. Supported Standing and Supported Stepping Devices for Children with Non-Ambulant Cerebral Palsy: An Interdependence and F-Words Focus. Int J Environ Res Public Health. 2024 May 23;21(6):669. doi: 10.3390/ijerph21060669. PubMed 38928915 ↗
  • Paleg GS, Smith BA, Glickman LB. Systematic review and evidence-based clinical recommendations for dosing of pediatric supported standing programs. Pediatr Phys Ther. 2013 Fall;25(3):232-47. doi: 10.1097/PEP.0b013e318299d5e7. PubMed 23797394 ↗
  • Verschuren O, Peterson MD, Leferink S, Darrah J. Muscle activation and energy-requirements for varying postures in children and adolescents with cerebral palsy. J Pediatr. 2014 Nov;165(5):1011-6. doi: 10.1016/j.jpeds.2014.07.027. Epub 2014 Aug 20. PubMed 25151195 ↗

Individual participant data

Plan to share: No — There is no plan to share individual participant data with other researchers.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for Jan 2028, 15 months after the start.

Of 216 non-industry observational studies under Cerebral Palsy, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 60. This study's planned 15 months is below that.

Counting every sponsor, half of 220 studies reached it within 21 months; a quarter within 8 and three quarters within 60.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 6, 2026
First posted
Nov 12, 2026
StartActual
Oct 1, 2026
Primary completionEst.
Jan 28, 2028
CompletionEst.
Jan 28, 2028
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 12, 2026
Show all 2 updates
  1. Nov 17, 2026
    Minor edits only
    + 1 other change: responsible party
  2. Nov 12, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07932015
Lead sponsor
Klaipėda University
Responsible party
Laura Zaliene (Principal Investigator, Klaipėda University) — Principal investigator
First posted
Nov 12, 2026
Start date
Oct 1, 2026
Primary completion
Jan 28, 2028 (estimated)
Completion
Jan 28, 2028 (estimated)
Last update
Nov 17, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion